Growth curve for girls with Turner syndrome.

A J Lyon, M A Preece, D B Grant

A growth chart for girls with Turner syndrome has been prepared using data from four published series of European patients, and evaluated using retrospective data on the heights of girls with Turner syndrome seen at this hospital. The results indicate that calculation of height standard deviation score from this chart allows a reasonable prediction of adult stature in any patient with Turner syndrome. In addition, the results indicate that while oestrogen treatment causes an initial acceleration of growth, it has no significant effect on adult height.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Romano, A. A., Dana, K., Bakker, B., Davis, D. A., Hunold, J. J., Jacobs, J., Lippe, B. (2009). Growth Response, Near-Adult Height, and Patterns of Growth and Puberty in Patients with Noonan Syndrome Treated with Growth Hormone. J. Clin. Endocrinol. Metab. 94: 2338-2344 [Abstract] [Full Text]  
• Hjerrild, B. E., Mortensen, K. H., Gravholt, C. H. (2008). Turner syndrome and clinical treatment. Br Med Bull 86: 77-93 [Abstract] [Full Text]  
• Davenport, M. L., Crowe, B. J., Travers, S. H., Rubin, K., Ross, J. L., Fechner, P. Y., Gunther, D. F., Liu, C., Geffner, M. E., Thrailkill, K., Huseman, C., Zagar, A. J., Quigley, C. A. (2007). Growth Hormone Treatment of Early Growth Failure in Toddlers with Turner Syndrome: A Randomized, Controlled, Multicenter Trial. J. Clin. Endocrinol. Metab. 92: 3406-3416 [Abstract] [Full Text]  
• Bondy, C. A., for The Turner Syndrome Consensus Study Group, (2007). Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92: 10-25 [Abstract] [Full Text]  
• Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., Hojbjerg Gravholt, C. (2006). Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome. J. Clin. Endocrinol. Metab. 91: 3897-3902 [Abstract] [Full Text]  
• Hamelin, C. E., Anglin, G., Quigley, C. A., Deal, C. L., on behalf of the Canadian Growth Hormone Advisory, (2006). Genomic Imprinting in Turner Syndrome: Effects on Response to Growth Hormone and on Risk of Sensorineural Hearing Loss. J. Clin. Endocrinol. Metab. 91: 3002-3010 [Abstract] [Full Text]  
• Soriano-Guillen, L., Coste, J., Ecosse, E., Leger, J., Tauber, M., Cabrol, S., Nicolino, M., Brauner, R., the StaTur Study Group, , Chaussain, J.-L., Carel, J.-C. (2005). Adult Height and Pubertal Growth in Turner Syndrome after Treatment with Recombinant Growth Hormone. J. Clin. Endocrinol. Metab. 90: 5197-5204 [Abstract] [Full Text]  
• Abbott, R., Atkin, L-M, Davies, P. (2005). Predicting adult height in Turner syndrome. Eur J Endocrinol 152: 917-917 [Full Text]  
• Bridges, N. (2005). New indications for growth hormone. EDUCATION AND PRACTICE 90: ep7-ep9 [Full Text]  
• The Canadian Growth Hormone Advisory Committee, (2005). Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial. J. Clin. Endocrinol. Metab. 90: 3360-3366 [Abstract] [Full Text]  
• American Society for Parenteral and Enteral Nutrit, , and Task Force on Standards for Specialized Nutrit, , Jane Balint, , Catherine Crill, , Kimberly Klotz, (2005). Standards for Specialized Nutrition Support: Hospitalized Pediatric Patients. Nutr Clin Pract 20: 103-116 [Full Text]  
• Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., Bowers, C. Y. (2005). Endocrine Control of Body Composition in Infancy, Childhood, and Puberty. Endocr. Rev. 26: 114-146 [Abstract] [Full Text]  
• Sybert, V. P., McCauley, E. (2004). Turner's Syndrome. NEJM 351: 1227-1238 [Full Text]  
• Massa, G., Heinrichs, C., Verlinde, S., Thomas, M., Bourguignon, J. P., Craen, M., Francois, I., Du Caju, M., Maes, M., De Schepper, J. (2003). Late or Delayed Induced or Spontaneous Puberty in Girls with Turner Syndrome Treated with Growth Hormone Does Not Affect Final Height. J. Clin. Endocrinol. Metab. 88: 4168-4174 [Abstract] [Full Text]  
• van Pareren, Y. K., de Muinck Keizer-Schrama, S. M. P. F., Stijnen, T., Sas, T. C. J., Jansen, M., Otten, B. J., Hoorweg-Nijman, J. J. G., Vulsma, T., Stokvis-Brantsma, W. H., Rouwe, C. W., Reeser, H. M., Gerver, W.-J., Gosen, J. J., Rongen-Westerlaken, C., Drop, S. L. S. (2003). Final Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment in Three Dosages and Low Dose Estrogens. J. Clin. Endocrinol. Metab. 88: 1119-1125 [Abstract] [Full Text]  
• Frias, J. L., Davenport, M. L., Committee on Genetics, , Section on Endocrinology, (2003). Health Supervision for Children With Turner Syndrome. Pediatrics 111: 692-702 [Abstract] [Full Text]  
• Myrelid, A, Gustafsson, J, Ollars, B, Anneren, G (2002). Growth charts for Down's syndrome from birth to 18 years of age. Arch. Dis. Child. 87: 97-103 [Abstract] [Full Text]  
• Quigley, C. A., Crowe, B. J., Anglin, D. G., Chipman, J. J. (2002). Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final Height. J. Clin. Endocrinol. Metab. 87: 2033-2041 [Abstract] [Full Text]  
• Elsheikh, M., Dunger, D. B., Conway, G. S., Wass, J. A. H. (2002). Turner's Syndrome in Adulthood. Endocr. Rev. 23: 120-140 [Abstract] [Full Text]  
• Saenger, P., Wikland, K. A., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., Lippe, B., Pasquino, A. M., Ranke, M. B., Rosenfeld, R., Silberbach, M. (2001). Recommendations for the Diagnosis and Management of Turner Syndrome. J. Clin. Endocrinol. Metab. 86: 3061-3069 [Abstract] [Full Text]  
• Reiter, E. O., Blethen, S. L., Baptista, J., Price, L. (2001). Early Initiation of Growth Hormone Treatment Allows Age-Appropriate Estrogen Use in Turner's Syndrome. J. Clin. Endocrinol. Metab. 86: 1936-1941 [Abstract] [Full Text]  
• Kirk, J M W, Betts, P R, Butler, G E, Donaldson, M D C, Dunger, D B, Johnston, D I, Kelnar, C J H, Price, D A, Wilton, P, Group, t. U. K. E. (2001). Short stature in Noonan syndrome: response to growth hormone therapy. Arch. Dis. Child. 84: 440-443 [Abstract] [Full Text]  
• Johnston, D I, Betts, P, Dunger, D, Barnes, N, Swift, P G F, Buckler, J M H, Butler, G E (2001). A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis. Arch. Dis. Child. 84: 76-81 [Abstract] [Full Text]  
• Ranke, M. B., Lindberg, A., Chatelain, P., Wilton, P., Cutfield, W., Albertsson-Wikland, K., Price, D. A. (2000). Prediction of Long-Term Response to Recombinant Human Growth Hormone in Turner Syndrome: Development and Validation of Mathematical Models. J. Clin. Endocrinol. Metab. 85: 4212-4218 [Abstract] [Full Text]  
• Chernausek, S. D., Attie, K. M., Cara, J. F., Rosenfeld, R. G., Frane, J. (2000). Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height. J. Clin. Endocrinol. Metab. 85: 2439-2445 [Abstract] [Full Text]  
• Hall;, D. M B, VOSS, L. D (2000). Growth monitoring. Arch. Dis. Child. 82: 10-15 [Full Text]  
• Guyda, H. (1999). Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved?. J. Clin. Endocrinol. Metab. 84: 4307-4316 [Full Text]  
• (1999). Growth-Promoting Strategies in Turner's Syndrome. J. Clin. Endocrinol. Metab. 84: 4345-4348 [Full Text]  
• (1999). Final Height of Patients with Turner's Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy. J. Clin. Endocrinol. Metab. 84: 4510-4515 [Abstract] [Full Text]  
• (1999). Growth Retardation in Turner Syndrome: Aneuploidy, Rather Than Specific Gene Loss, May Explain Growth Failure. J. Clin. Endocrinol. Metab. 84: 4578-4582 [Abstract] [Full Text]  
• Sas, T. (1999). Normalization of Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment: Results of a Randomized Dose-Response Trial. J. Clin. Endocrinol. Metab. 84: 4607-4612 [Abstract] [Full Text]  
• Vance, M. L., Mauras, N. (1999). Growth Hormone Therapy in Adults and Children. NEJM 341: 1206-1216 [Full Text]  
• Azcona, C., Bareille, P., Stanhope, R. (1999). Lesson of the week: Turner's syndrome mosaicism in patients with a normal blood lymphocyte karyotype. BMJ 318: 856-857 [Full Text]  
• Betts, P R, Butler, G E, Donaldson, M D C, Dunger, D B, Johnston, D I, Kelnar, C J H, Kirk, J, Price, D A, Wilton, P, the UK KIGS Executive Group on behalf of the parti, (1999). A decade of growth hormone treatment in girls with Turner syndrome in the UK. Arch. Dis. Child. 80: 221-225 [Abstract] [Full Text]  
• Sas, T. C J, Keizer-Schrama, S M P F d. M., Stijnen, T., van Teunenbroek, A, Hokken-Koelega, A C S, Waelkens, J J J, Massa, G G, Vulsma, T., Gerver, W J, Reeser, H M, de Waal, H E D.-v., Jansen, M, Drop, S L S, the Dutch Advisory Group on Growth Hormone, (1999). Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Arch. Dis. Child. 80: 36-41 [Abstract] [Full Text]  
• Mulligan, J, Voss, L D, McCaughey, E S, Bailey, B J R, Betts;, P R, HALL, D. (1998). Growth monitoring: testing the new guidelines • Commentary. Arch. Dis. Child. 79: 318-322 [Abstract] [Full Text]  
• Plotnick, L., Attie, K. M., Blethen, S. L., Sy, J. P. (1998). Growth Hormone Treatment of Girls With Turner Syndrome: The National Cooperative Growth Study Experience. Pediatrics 102: 479-481 [Abstract] [Full Text]  
• Carel, J.-C., Mathivon, L., Gendrel, C., Ducret, J.-P., Chaussain, J.-L. (1998). Near Normalization of Final Height with Adapted Doses of Growth Hormone in Turner's Syndrome. J. Clin. Endocrinol. Metab. 83: 1462-1466 [Abstract] [Full Text]  
• Lagrou, K., Xhrouet-Heinrichs, D., Heinrichs, C., Craen, M., Chanoine, J.-P., Malvaux, P., Bourguignon, J.-P. (1998). Age-Related Perception of Stature, Acceptance of Therapy, and Psychosocial Functioning in Human Growth Hormone-Treated Girls with Turner's Syndrome. J. Clin. Endocrinol. Metab. 83: 1494-1501 [Abstract] [Full Text]  
• Pasquino, A. M., Passeri, F., Pucarelli, I., Segni, M., Municchi, G. (1997). Spontaneous Pubertal Development in Turner's Syndrome. J. Clin. Endocrinol. Metab. 82: 1810-1813 [Abstract] [Full Text]  
• Rongen-Westerlaken, C., van Es, A., Wit, J.-M., Otten, B. J., De Muinck Keizer-Schrama, S. M. P. F., Drayer, N. M., Oostdijk, W., Delemarre-vd Waal, H. A., Gons, M. H., Waelkens, J. J. J., Van den Brande, J. L. (1992). Growth Hormone Therapy in Turner's Syndrome: Impact of Injection Frequency and Initial Bone Age. Arch Pediatr Adolesc Med 146: 817-820 [Abstract]